-
limited. No immunotherapy for meningiomas has yet gained FDA approval, though early-phase trials targeting IFN-alpha and PD-1 have been conducted. Emerging evidence highlights the crucial role of the immune
Enter an email to receive alerts for optimization-nonlinear-functions-"Prof" positions